<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26790405</article-id><article-id pub-id-type="pmc">4719684</article-id><article-id pub-id-type="publisher-id">1156</article-id><article-id pub-id-type="doi">10.1186/s13063-016-1156-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Are glucose levels, glucose variability and autonomic control influenced by inspiratory muscle exercise in patients with type 2 diabetes? Study protocol for a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Schein</surname><given-names>ASO</given-names></name><address><email>andressasilveiradeoliveira@yahoo.com.br</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Correa</surname><given-names>APS</given-names></name><address><email>aninhacorrea.fst@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Casali</surname><given-names>Karina Rabello</given-names></name><address><email>rabello.casali@unifesp.br</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Schaan</surname><given-names>Beatriz D.</given-names></name><address><email>beatrizschaan@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff4"/><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff1"><label/>Exercise Pathophysiology Research Laboratory, Hospital de Cl&#x000ed;nicas de Porto Alegre, Porto Alegre, Rio Grande do Sul Brazil </aff><aff id="Aff2"><label/>Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales Australia </aff><aff id="Aff3"><label/>Institute of Science and Technology, Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil </aff><aff id="Aff4"><label/>Graduate Program in Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul Brazil </aff><aff id="Aff5"><label/>Endocrine Division, Hospital de Cl&#x000ed;nicas de Porto Alegre, Porto Alegre, Rio Grande do Sul Brazil </aff></contrib-group><pub-date pub-type="epub"><day>20</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>17</volume><elocation-id>38</elocation-id><history><date date-type="received"><day>26</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>5</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; Schein et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Physical exercise reduces glucose levels and glucose variability in patients with type 2 diabetes. Acute inspiratory muscle exercise has been shown to reduce these parameters in a small group of patients with type 2 diabetes, but these results have yet to be confirmed in a well-designed study. The aim of this study is to investigate the effect of acute inspiratory muscle exercise on glucose levels, glucose variability, and cardiovascular autonomic function in patients with type 2 diabetes.</p></sec><sec><title>Methods/design</title><p>This study will use a randomized clinical trial crossover design. A total of 14 subjects will be recruited and randomly allocated to two groups to perform acute inspiratory muscle loading at 2&#x000a0;% of maximal inspiratory pressure (PImax, placebo load) or 60&#x000a0;% of PImax (experimental load).</p></sec><sec><title>Discussion</title><p>Inspiratory muscle training could be a novel exercise modality to be used to decrease glucose levels and glucose variability.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02292810">NCT02292810</ext-link>.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>breathing exercises</kwd><kwd>exercise</kwd><kwd>glucose</kwd><kwd>type 2 diabetes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Hyperglycemia is the main cause of the clinical manifestations and acute and chronic complications of diabetes mellitus. Reducing glucose levels through nonpharmacological [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] and pharmacological therapy is the cornerstone of type 2 diabetes management [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Goals for optimal diabetes management include reducing glycated hemoglobin (HbA1c) levels to 7&#x000a0;% and implementing a number of cardiovascular risk reduction strategies [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p><p>However, chronic complications of diabetes can develop even when these targets are met. This can be attributed to genetic and epigenetic factors [<xref ref-type="bibr" rid="CR7">7</xref>], disruption of repair mechanisms [<xref ref-type="bibr" rid="CR8">8</xref>], and, possibly, high glucose variability even when optimal HbA1c levels are achieved. Glucose variability is the fluctuation of glucose levels during the day, including episodes of hypoglycemia and hyperglycemia [<xref ref-type="bibr" rid="CR9">9</xref>]. Measurement of glucose levels in intersticium throughout the day by continuous glucose monitoring systems [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] or periodic capillary blood-glucose measurements [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>] have been used to evaluate glucose variability. Several conventional measures are available to quantify this parameter and have been widely reported in the literature over the past years [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], including the mean amplitude of glycemic excursions [<xref ref-type="bibr" rid="CR16">16</xref>], the standard deviation of glucose, and the mean of daily differences [<xref ref-type="bibr" rid="CR17">17</xref>]. Non-conventional methods, which use mathematical and statistical analysis of the dynamic characteristics of glucose levels, as measured using continuous glucose monitoring systems, through spectral analysis and symbolic analyses, were recently reported [<xref ref-type="bibr" rid="CR18">18</xref>].</p><p>Exercise training, consisting of aerobic exercise, resistance exercise, or a combination of both, is a useful tool for reducing HbA1c levels in type 2 diabetes [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. It is also associated with several other benefits, including improved blood pressure control [<xref ref-type="bibr" rid="CR21">21</xref>], reduction of skeletal muscle frailty [<xref ref-type="bibr" rid="CR22">22</xref>], reduction of inflammation [<xref ref-type="bibr" rid="CR23">23</xref>], and improved cardiovascular autonomic function [<xref ref-type="bibr" rid="CR24">24</xref>]. Additionally, a recent study showed that an acute bout of aerobic or resistance exercise is associated with lower glucose variability [<xref ref-type="bibr" rid="CR18">18</xref>], opening a new venue of benefits to explore.</p><p>Considering that many diabetic patients, especially those with autonomic neuropathy, have poor exercise tolerance or are completely unable to perform conventional exercises [<xref ref-type="bibr" rid="CR25">25</xref>], alternatives should be sought. Inspiratory muscle training is a modality that has proven benefits in several clinical situations [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], such as improving cardiopulmonary capacity and normalizing derangements in autonomic function [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. In patients with type 2 diabetes, this exercise modality can improve the strength and resistance of inspiratory muscles [<xref ref-type="bibr" rid="CR29">29</xref>] and reduce glucose levels and glucose variability [<xref ref-type="bibr" rid="CR30">30</xref>]. We speculate that, in type 2 diabetes, beyond reflecting the well-known improvement in insulin sensitivity induced by muscle contractions, inspiratory exercise would also yield improvements in cardiovascular autonomic function [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Thus, the aim of this study is to investigate the effect of acute inspiratory muscle exercise on glucose levels, glucose variability, and autonomic control in patients with type 2 diabetes.</p></sec><sec id="Sec2"><title>Methods/design</title><sec id="Sec3"><title>Study design</title><p>This study is a randomized clinical trial with a crossover design.</p></sec><sec id="Sec4"><title>Outcome measures</title><p>The difference in glucose levels before and after exercise (evaluated by continuous glucose monitoring systems; glucose level after exercise minus glucose level before exercise) is the primary outcome measure. The secondary outcome measures are: (1) changes in glucose variability, which will also be evaluated by continuous glucose monitoring systems through conventional (mean amplitude of glucose excursion, variation of glucose, coefficient of variation of glucose, and standard deviation of glucose) and non-conventional indices (spectral analysis and symbolic patterns: no variation); (2) changes in cardiovascular autonomic control, which will be evaluated&#x000a0;by blood pressure variability and heart rate variability&#x000a0;(measures of power spectral density of low frequency, high frequency and very low frequency bands). Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> shows the measures that will be evaluated to achieve the desired results.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Evaluated measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Time point</th><th>Data collection</th><th>Measure</th><th>Outcomes</th></tr></thead><tbody><tr><td>Pre-evaluation</td><td>Blood and urine analysis</td><td>Glycemia, HbA1c, microalbuminuria and creatinine</td><td>Metabolic responses</td></tr><tr><td/><td>Cardiovascular autonomic assessment</td><td>Ewing tests</td><td>Diagnosis of cardiovascular autonomic neuropathy</td></tr><tr><td/><td>International Physical Activity Questionnaire</td><td>Survey</td><td>Physical activity estimates</td></tr><tr><td/><td>Inspiratory muscle test</td><td>maximal inspiratory mouth pressure (PImax)</td><td>Inspiratory muscle strength</td></tr><tr><td/><td>Pulmonary function test</td><td>maximum voluntary ventilation, forced vital capacity, vital capacity, forced expiratory volume (1&#x000a0;s), forced expiratory volume (1&#x000a0;s)/vital capacity and forced expiratory volume (1&#x000a0;s)/forced vital capacity</td><td>Pulmonary flow and volume</td></tr><tr><td/><td>Rest electrocardiogram</td><td>12-lead electrocardiogram</td><td>Electrical activity of the heart</td></tr><tr><td/><td>Cardiopulmonary exercise testing</td><td>VO<sub>2peak</sub>, VCO<sub>2peak</sub>, R<sub>peak</sub>, VE<sub>peak</sub>, VE&#x02044;VO<sub>2peak</sub>, VE&#x02044;VCO<sub>2peak</sub>
</td><td>Ventilatory and metabolic variables</td></tr><tr><td>At rest</td><td>Continuous glucose monitoring system</td><td>Glucose concentration</td><td>Glucose levels and variability</td></tr><tr><td/><td>Biopac system</td><td>Continuous recording of blood pressure</td><td>Blood pressure and heart rate variability in time and frequency domains</td></tr><tr><td rowspan="2">Controlled ventilation</td><td>Continuous glucose monitoring system</td><td>Glucose concentration</td><td>Glucose concentration and variability</td></tr><tr><td>Biopac system</td><td>Continuous recording of blood pressure</td><td>Blood pressure and heart rate variability in time and frequency domains</td></tr><tr><td rowspan="2">Inspiratory muscle exercise (2&#x000a0;% or 60&#x000a0;% of maximal inspiratory mouth pressure, PImax)</td><td>Continuous glucose monitoring system</td><td>Glucose concentration</td><td>Glucose levels and variability</td></tr><tr><td>Biopac system</td><td>Continuous recording of blood pressure</td><td>Blood pressure and heart rate variability in time and frequency domains</td></tr><tr><td rowspan="2">Recuperation</td><td>Continuous glucose monitoring system</td><td>Glucose concentration</td><td>Glucose concentration and variability</td></tr><tr><td>Biopac system</td><td>Continuous recording of blood pressure</td><td>Blood pressure and heart rate variability in time and frequency domains</td></tr></tbody></table><table-wrap-foot><p>HbA1c, glycated hemoglobin; PImax, inspiratory mouth pressure; R, respiratory exchange rate; VCO<sub>2</sub>peak: carbon dioxide output; VE, minute ventilation; VO<sub>2peak</sub>, peak oxygen uptake; VE&#x02044;VO<sub>2</sub>: ventilatory equivalent for oxygen; VE&#x02044;VCO<sub>2</sub>: ventilatory equivalent for carbon dioxide</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Sample size and power calculation</title><p>According to preliminary results obtained in our laboratory [<xref ref-type="bibr" rid="CR31">31</xref>], the sample size was estimated in 14 individuals with type 2 diabetes, allowing for a dropout rate of 10&#x000a0;%. This sample size would detect a 34&#x000a0;mg/dl difference in glucose levels between the intervention inspiratory load of 60&#x000a0;% and the placebo inspiratory load of 2&#x000a0;%, taking into account a standard deviation of 30&#x000a0;mg/dl, a statistical power of 80&#x000a0;%, and a type I error rate of 5&#x000a0;%. WinPepi software was used to calculate the sample size.</p></sec><sec id="Sec6"><title>Inclusion and exclusion criteria</title><p>The study will be conducted in patients with type 2 diabetes, diagnosed according to the National Diabetes Data Group criteria [<xref ref-type="bibr" rid="CR5">5</xref>]. The inclusion criteria will be age 30&#x000a0;years and older, HbA1c between 7.5 and 10&#x000a0;%, and stable clinical condition, to ensure safe performance of the trial protocols. Patients will be recruited from the Outpatient Endocrinology Clinic of Hospital de Cl&#x000ed;nicas de Porto Alegre, Brazil. All study methods described are in accordance with the CONSORT Statement [<xref ref-type="bibr" rid="CR32">32</xref>].</p><p>The exclusion criteria will consist of: insulin treatment, pregnancy, pulmonary disease (history of exercise-induced asthma), cardiac arrhythmias, chronic kidney disease (glomerular filtration rate &#x0003c;30&#x000a0;ml/min), exclusive use of beta blockers as antihypertensive therapy, current smoking, varicose veins, and musculoskeletal conditions that would hinder safe completion of the proposed exercise protocols.</p></sec><sec id="Sec7"><title>Randomization</title><p>The randomization sequence will be generated by computer. Randomization to the low-resistance inspiratory muscle exercise group (2&#x000a0;% of maximal inspiratory pressure (PImax), placebo load) or the high-resistance inspiratory muscle exercise group (60&#x000a0;% of PImax, experimental load) will be performed by an investigator assigned exclusively to this task, who will not participate in the recruitment, assessment, or intervention phases of the study.</p></sec><sec id="Sec8"><title>Data collection</title><p>Patients will be instructed to attend on three different days at the study laboratory for baseline evaluations, as follows:<list list-type="bullet"><list-item><p>Day 1: Urine collection and fasting blood draw for assessment of glucose, HbA1c, creatinine, and microalbuminuria; physical examination; Ewing tests for autonomic assessment; and completion of the International Physical Activity Questionnaire.</p></list-item><list-item><p>Day 2: Resting 12-lead electrocardiogram, inspiratory muscle and pulmonary function tests.</p></list-item><list-item><p>Day 3: Cardiopulmonary exercise testing.</p></list-item></list></p></sec><sec id="Sec9"><title>Autonomic neuropathy evaluation</title><p>The presence of cardiovascular autonomic neuropathy will be evaluated using digital electrocardiography (VNS-Rhythm Neurosoft, Ivanovo, Russia) as previously described [<xref ref-type="bibr" rid="CR33">33</xref>] and the five noninvasive cardiovascular tests proposed by Ewing [<xref ref-type="bibr" rid="CR34">34</xref>], as standardized in our institution [<xref ref-type="bibr" rid="CR35">35</xref>]. The heart rate, electrocardiographically monitored, will be evaluated after 5&#x000a0;min of resting and before and after deep breathing, the Valsalva maneuver, and standing. Three tests will be used to evaluate the heart rate response to (1) deep breathing, (2) lying-to-standing heart rate ratio, and (3) a Valsalva maneuver. Two tests of blood pressure control will be performed during (1) orthostatic hypotension and (2) sustained handgrip. Two or more abnormal test results will be deemed diagnostic of cardiovascular autonomic neuropathy. Heart rate variation will be assessed while patients are asked to breathe deeply at a rate of six breaths per minute while being monitored using three-lead electrocardiography. The maximum and minimum heart rate during each breathing cycle will be measured, and the mean difference over six cycles will be calculated. The heart rate ratio test will be performed after a period of rest in the supine position, and heart rate variability will be determined by calculating the maximal to minimal heart rate ratio: the ratio of the longest RR interval, measured around the 30th beat after standing up, to the shortest RR interval, measured around the 15th beat after standing up. The Valsalva maneuver will consist of forced exhalation into a mouthpiece with a pressure of 40&#x000a0;mmHg for 15&#x000a0;s, and the ratio of the maximum RR interval after this maneuver to the minimum RR interval during the maneuver will be calculated. Orthostatic hypotension will be defined as a decrease of 30&#x000a0;mmHg in systolic blood pressure when the individual voluntarily changes from the supine to the standing position. Measurements will be obtained at minutes 1 and 3 after standing up. Sustained muscle contraction will be measured by a handgrip dynamometer. The dynamometer will be first squeezed to maximum isometric contraction in the dominant hand. The highest of three measurements will be taken; then patients will be asked to hold at 30&#x000a0;% maximum for 3&#x000a0;min. A rise in diastolic blood pressure of&#x02009;&#x0003c;&#x02009;10&#x000a0;mmHg is considered an abnormal response.</p></sec><sec id="Sec10"><title>Inspiratory muscle testing</title><p>Inspiratory muscle function testing will be performed using a pressure transducer (MVD-500&#x000a0;V.1.1 Microhard System; Globalmed, Porto Alegre, Brazil), connected to a system containing two one-way valves (DHD Inspiratory Muscle Trainer, Chicago, IL, USA) and equipped with a 2&#x000a0;mm diameter orifice to relieve facial muscle pressure. Patients will be instructed to remain seated, with elbows resting on the chair; a nasal clip will be used during all maneuvers. The PImax will be determined after patients take a deep breath at tidal volume, followed by slow exhalation to residual volume, and then quickly perform a maximal inspiration against the occluded circuit with a small air leak. The test will be repeated at least three times, with a 1&#x000a0;min interval between repetitions, to obtain six measurements with &#x0003c;10&#x000a0;% variation [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. The values obtained from the PImax readings will be verified directly on the transducer. Predicted values will be corrected for age and sex.</p></sec><sec id="Sec11"><title>Pulmonary function</title><p>Measurements of forced vital capacity, vital capacity, forced expiratory volume in 1&#x000a0;s, and their ratios (forced expiratory volume (1&#x000a0;s)/vital capacity and forced expiratory volume (1&#x000a0;s)/forced vital capacity) will be obtained using a computerized spirometer (Eric Jaeger GmbH, W&#x000fc;rzburg, Germany), as recommended by the American Thoracic Society [<xref ref-type="bibr" rid="CR38">38</xref>], and results will be expressed as a percentage of predicted parameter. For maximum voluntary ventilation, subjects will be instructed to breathe as deeply and quickly as possible for 15&#x000a0;s; volume measurement will begin after the patient is able to achieve and maintain maximum effort [<xref ref-type="bibr" rid="CR38">38</xref>].</p></sec><sec id="Sec12"><title>Cardiopulmonary exercise testing</title><p>Maximal functional capacity will be assessed by means of an incremental exercise test to be performed on a treadmill (Inbramed 10200, Porto Alegre, Brazil), using a ramp protocol with a speed of 2&#x02013;6&#x000a0;km/h and increasing slope of 4&#x02013;10&#x000a0;% to reach exhaustion in about 10&#x000a0;min [<xref ref-type="bibr" rid="CR36">36</xref>]. A 12-lead electrocardiogram tracing will be obtained every 1&#x000a0;min (Nihon Khoden Corp., Tokyo, Japan), and blood pressure will be measured every 2&#x000a0;min with a standard cuff sphygmomanometer. During the test, gas exchange variables will be measured breath-by-breath with a previously validated system (Metalyzer3B, CPX System; Cortex, Leipzig, Germany). Ventilatory and metabolic variables will be analyzed throughout the test. Peak oxygen uptake (VO<sub>2peak</sub>) will be defined as the highest value reached during the test.</p></sec><sec id="Sec13"><title>Study intervention</title><p>After baseline evaluations, all patients will be instructed to present to the laboratory, three times per week for 2&#x000a0;weeks, for completion of the intervention stage of the study protocol, as follows:<list list-type="bullet"><list-item><p>Day 1: Placement of the continuous glucose monitoring system. Patients should arrive at 8:00&#x000a0;a.m. for device placement. Patients using beta blockers will be advised to discontinue their medication 24&#x000a0;hours before the next study visit.</p></list-item><list-item><p>Day 2: Acute inspiratory muscle exercise protocol (2&#x000a0;% or 60&#x000a0;% of PImax). Patients should arrive at 10:00&#x000a0;a.m. and will be instructed to rest in the supine position for 10&#x000a0;min for collection of baseline glucose, continuous blood pressure, and heart rate measurements. Participants will then start controlled ventilation for 10&#x000a0;min. A 40-minute interval will be allowed to elapse before the start of acute inspiratory muscle loading. Pursuant to random group allocation, participants will receive loading to 2&#x000a0;% of PImax (low resistance, placebo load) for 10&#x000a0;min or to 60&#x000a0;% of PImax (high resistance, experimental load) until task failure. At the end of the exercise protocol, a 10-min recovery record will be obtained. Glucose levels will also be measured by capillary sample before and after the protocol reported above. Arterial oxygen saturation (SpO<sub>2</sub>) mean arterial pressure, end-tidal carbon dioxide, calf blood flow, and calf vascular conductance will be measured during all protocols.</p></list-item><list-item><p>Day 3: Continuous glucose monitoring system removal. Patients will be instructed to return to the laboratory at noon for removal of the device.</p></list-item></list></p><p>One week following these interventions, all subjects will return to the study facility to repeat these procedures, but using another randomized load for inspiratory muscle exercises.</p><p>The experimental sessions will take place at the Hospital de Cl&#x000ed;nicas de Porto Alegre Exercise Pathophysiology Research Laboratory. All experiments will be performed in a temperature-controlled room and all subjects will be instructed to refrain from consuming caffeinated beverages and alcohol for at least 12&#x000a0;hours and from exercise for at least 24&#x000a0;hours prior to the evaluation. Continuous assessment of blood-glucose levels and blood pressure will be performed before, during, and after all protocols. Patients will be asked to follow their habitual diet and keep a detailed food intake record across the 3&#x000a0;days of continuous glucose monitoring system use.</p></sec><sec id="Sec14"><title>Glucose variability evaluation</title><p>Subjects will be admitted to the laboratory at 8:00&#x000a0;a.m., 24&#x000a0;hours before the acute inspiratory muscle exercise session, for placement of the continuous glucose monitoring system sensor (Enlite Glucose Sensor, Medtronic MiniMed Inc., Northridge, CA, USA). Glucose data are obtained every 5&#x000a0;min, providing a total of 288 readings per day.</p><p>Individuals will be instructed to perform at least four capillary blood-glucose measurements per day, before each meal, for calibration. The monitoring will be performed by the patients themselves, with a digital glucometer (Accu-Check Performa, Roche Diagnostics, Mannheim, Germany). Along with the glucometer, diaries will be delivered to patients, in which they should record the glucose values at each measurement and also details of all meals ingested during the period of continuous glucose monitoring.</p><p>Glucose variability will be evaluated using conventional and non-conventional analyses. Conventional analysis will be conducted using the statistical properties of the glycemic series classically used [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>] and non-conventional analysis of glucose variability will be conducted by application of two methods to the glucose series, based on spectral analysis and symbolic dynamics. Spectral analysis is a linear method that allows quantification of the oscillatory components from a time series by autoregressive models, and is widely applied to heart rate and arterial pressure series [<xref ref-type="bibr" rid="CR41">41</xref>]. Symbolic dynamics relies on the calculation of Shannon entropy of the distribution of patterns lasting three measures and the classification of frequent deterministic patterns lasting three measures, and distributes deterministic patterns of the group into four variations [<xref ref-type="bibr" rid="CR42">42</xref>].</p></sec><sec id="Sec15"><title>Cardiovascular autonomic control evaluation</title><p>Cardiovascular autonomic control will be measured continually before the protocol (during a 10&#x000a0;min rest), during the controlled ventilation plus acute inspiratory muscle exercise protocol (2&#x000a0;% or 60&#x000a0;% of PImax), and throughout the recovery period, using a noninvasive blood pressure device (NIBP100D system; Biopac, Santa Barbara, CA, USA) with a general purpose amplifier module (DA100; Biopac), according to methodological guidelines provided by Sherwood <italic>et al.</italic> [<xref ref-type="bibr" rid="CR43">43</xref>]. This system acquires the blood pressure wave at a sampling frequency of 1000&#x000a0;Hz through a cuff placed on the middle phalanx of the third finger. Beat-to-beat time series of systolic blood pressure and pulse interval will be constructed from blood pressure recording data; their variances correspond to heart rate variability and blood pressure variability, respectively. In addition, spectral analysis, using an autoregressive model, will be applied to estimate the center frequency and power of each relevant oscillatory component [<xref ref-type="bibr" rid="CR41">41</xref>]. The spectral bands for human beings are defined as: very low frequency, 0.0 to 0.04&#x000a0;Hz; low frequency, 0.04 to 0.15&#x000a0;Hz; and high frequency, 0.15 to 0.40&#x000a0;Hz, as described elsewhere [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec><sec id="Sec16"><title>Controlled ventilation</title><p>Individuals will be placed in the supine position for measurement of respiratory rate, heart rate, SpO<sub>2</sub> by pulse oximetry, and mean arterial pressure, which will be measured using an automated sphygmomanometer (Dinamap 1846 SX/P, Critikon, Tampa, FL, USA) once per minute during the test. The glucose and blood pressure, calf blood flow (which will be measured by venous occlusion plethysmography (Hokanson TL-400, Bellevue, WA, USA)) will be recorded continuously.</p><p>Inspiratory volume will be assessed using a pneumotachograph (Pneumotach3700 series, Hans Rudolph, Kansas City, MO, USA). The end-tidal carbon dioxide concentration will be measured by oxycapnography (Takaoka Oxicap, S&#x000e3;o Paulo, Brazil) and maintained at eupneic levels during both protocols via addition of CO<sub>2</sub> to the inspiratory circuit. Participants will be instructed to maintain a breathing frequency of 15 breaths per min and a duty cycle (<italic>T</italic><sub>I</sub>/<italic>T</italic><sub>Tot</sub>) of 0.7 by listening to an audio signal with distinct inspiratory and expiratory tones, and visual feedback will be displayed.</p></sec><sec id="Sec17"><title>Acute inspiratory muscle exercise</title><p>This protocol was developed by Dempsey <italic>et al.</italic> [<xref ref-type="bibr" rid="CR44">44</xref>] to reduce diaphragm blood flow and cause fatigue. During the protocol, individuals will breathe continuously through a two-way valve (Hans Rudolph, 2600 series, Shawnee, KS, USA) with low resistance (2&#x000a0;% of PImax) connected to an inspiratory resistance obtained by a threshold inspiratory muscle trainer (DHDInspiratory Muscle Trainer, Chicago, IL) or, for higher inspiratory pressures (60&#x000a0;% of PImax), to a POWERbreathe&#x000ae; inspiratory muscle trainer (Southam, UK). Inspiratory pressure will be continuously recorded and displayed on a computer screen shared through a television, providing visual feedback; the 10-point Borg scale [<xref ref-type="bibr" rid="CR45">45</xref>] will be used to access inspiratory effort at task failure. Inability to maintain breathing will be defined as a reduction of PImax to less than 80&#x000a0;% of the prescribed value during three consecutive breaths [<xref ref-type="bibr" rid="CR38">38</xref>]. For the placebo experiments conducted at 2&#x000a0;% of PImax, measurements will cease at 10&#x000a0;min. The sequence of experiments, induction of the inspiratory muscle metaboreflex (60&#x000a0;% of PImax), or allocation to the placebo experiment (2&#x000a0;% of PImax), will be randomized, and experiments will be conducted 1&#x000a0;week apart.</p><p>In both protocols, baseline data will be collected during 10&#x000a0;min of spontaneous breathing. After this period, a controlled ventilation protocol will be initiated, and individuals instructed to maintain a breathing frequency of 15 breaths per min and a duty cycle (<italic>T</italic><sub>I</sub>/<italic>T</italic><sub>Tot</sub>) of 0.7 by listening to an audio signal with distinct inspiratory and expiratory tones for 10&#x000a0;min. Calf blood flow will be measured by venous occlusion plethysmography (Hokanson, TL-400, Bellevue, WA, USA) every 10&#x000a0;s in the non-dominant lower limb. Calf vascular conductance will be calculated as calf blood flow divided by mean arterial pressure [<xref ref-type="bibr" rid="CR46">46</xref>]. Blood pressure will be monitored once a minute using an automated monitor (Dinamap, USA), and heart rate will be monitored continuously throughout the protocol.</p></sec><sec id="Sec18"><title>Ethics and data protection issues</title><p>Participation will be voluntary, and all ethical principles of confidentiality and data protection will be followed. All subjects will have to sign a standardized informed consent form prior to participating in the study. All procedures will be explained to participants, and information about the aim, design, potential risks and benefits, and all relevant details of the study will be provided in the informed consent form. The data obtained by the study will be available to the participant and to any other authorized person, and may be used anonymously for academic scientific purposes. The study protocol was approved by the Institutional Review Board of Hospital de Cl&#x000ed;nicas de Porto Alegre, Brazil (number 14&#x02013;0194) and registered at ClinicalTrials.gov (NCT02292810).</p></sec><sec id="Sec19"><title>Safety assessment</title><p>Data on all adverse events will be collected and included in medical reports, which will be forwarded to the health authorities. To ensure patient safety, if any adverse events occur at any time during the study, participants will be monitored for up to 4&#x000a0;weeks after study exit.</p></sec><sec id="Sec20"><title>Statistical analysis</title><p>Data will be expressed as means and standard deviations or medians and interquartile ranges for nonparametric variables. Two-way analysis of variance (ANOVA) for repeated measures will be used to evaluate averages before and after acute inspiratory muscle exercise, comparing the placebo (2&#x000a0;% of PImax) and intervention (60&#x000a0;% of PImax) loads. Pearson correlation coefficients will be used to evaluate the association between components of cardiovascular autonomic control and glucose levels. For nonparametric variables, Spearman correlation will be used. The statistical power will be 80&#x000a0;% and differences will be considered significant for <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05. All analyses will be performed using SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA).</p></sec></sec><sec id="Sec21"><title>Discussion</title><p>Exercise programs have traditionally emphasized aerobic exercise, because of its well-known cardiovascular [<xref ref-type="bibr" rid="CR47">47</xref>], metabolic [<xref ref-type="bibr" rid="CR48">48</xref>], and autonomic benefits in type 2 diabetes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Resistance training also has favorable effects on muscle strength, abdominal fat, insulin sensitivity [<xref ref-type="bibr" rid="CR22">22</xref>], and blood pressure [<xref ref-type="bibr" rid="CR21">21</xref>]. Furthermore, combined exercise is also beneficial for metabolic parameters [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] and glucose variability in subjects with type 2 diabetes [<xref ref-type="bibr" rid="CR18">18</xref>]. However, as not all patients tolerate conventional exercise and some find it difficult to adhere to fitness programs, alternatives must be developed to enable these patients to obtain the benefits of physical exercise. Inspiratory muscle training is a novel exercise modality that has demonstrated impressive beneficial effects on inspiratory muscle strength and resistance [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] and in reduction of glucose variability [<xref ref-type="bibr" rid="CR30">30</xref>]. However, given the relatively small sample size of our preliminary study [<xref ref-type="bibr" rid="CR30">30</xref>], we planned to examine this question in greater depth through a new study with a larger sample of patients with type 2 diabetes, seeking to confirm that a single bout of inspiratory muscle exercise may provide a benefit similar to that achieved with aerobic exercise on glucose levels and glucose variability. In brief, this study will be conducted to evaluate glucose levels, glucose variability, and cardiovascular autonomic responses at rest, during, and after a session of acute inspiratory muscle exercise performed under two resistance loads (low, 2&#x000a0;% of PImax; high, 60&#x000a0;% of PImax).</p></sec><sec id="Sec22"><title>Trial status</title><p>The trial is currently in the recruitment phase. Each patient is scheduled to attend nine hospital visits, and the total data collection time will be 10&#x000a0;months.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANOVA</term><def><p>analysis of variance</p></def></def-item><def-item><term>CONSORT</term><def><p>Consolidated Standards of Reporting Trials</p></def></def-item><def-item><term>HbA1c</term><def><p>glycated hemoglobin</p></def></def-item><def-item><term>PImax</term><def><p>maximal inspiratory pressure</p></def></def-item><def-item><term>SpO<sub>2</sub></term><def><p>oxygen saturation</p></def></def-item><def-item><term>VO<sub>2</sub>peak</term><def><p>peak oxygen uptake.</p></def></def-item></def-list></glossary><fn-group><fn><p>ASO Schein and APS Correa contributed equally to this work.</p></fn><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>ASOS coordinated the recruitment. She participated in the sequence alignment, and drafted the manuscript. APSC participated in the sequence alignment, will perform the statistical analysis and drafted this manuscript. KRC participated in the sequence alignment and will participate in data analysis procedures. She reviewed and approved this manuscript. BDS is the main investigator of the study. She participated in the coordination of all tasks, will participate in data analysis procedures, and reviewed and approved the manuscript. All authors read and approved the final manuscript.</p></fn><fn><p><bold>Authors&#x02019; information</bold></p><p>ASOS is a PhD student in the Postgraduate Program of Cardiology, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</p><p>APSC is a post-doctoral student in the Postgraduate Program of Endocrinology, School of Medicine, Universidade Federal do Rio Grande do Sul. She is a collaborator of the Faculty of Health Sciences, University of Sydney, Lidcombe, NSW, Australia.</p><p>KRC is a professor in the Department of Science and Technology, Science and Technology Institute, Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Jos&#x000e9; dos Campos, S&#x000e3;o Paulo, Brazil.</p><p>BDS works in the Endocrine Division, Hospital de Cl&#x000ed;nicas de Porto Alegre, RS, Brazil, and is a professor in Postgraduate Program of Endocrinology, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by a grant from the Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior, Brazil. This study was supported by Fundo de Incentivo &#x000e0; Pesquisa do Hospital de Cl&#x000ed;nicas de Porto Alegre. BDS was the recipient of an educational scholarship from Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldhaber-Fiebert</surname><given-names>JD</given-names></name><name><surname>Goldhaber-Fiebert</surname><given-names>SN</given-names></name><name><surname>Tristan</surname><given-names>ML</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name></person-group><article-title>Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><issue>1</issue><fpage>24</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.1.24</pub-id><pub-id pub-id-type="pmid">12502654</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colberg</surname><given-names>SR</given-names></name><name><surname>Sigal</surname><given-names>RJ</given-names></name><name><surname>Fernhall</surname><given-names>B</given-names></name><name><surname>Regensteiner</surname><given-names>JG</given-names></name><name><surname>Blissmer</surname><given-names>BJ</given-names></name><name><surname>Rubin</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>12</issue><fpage>e147</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2337/dc10-9990</pub-id><pub-id pub-id-type="pmid">21115758</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>UK Prospective Diabetes Study (UKPDS) Group</collab></person-group><article-title>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)</article-title><source>Lancet.</source><year>1998</year><volume>352</volume><issue>9131</issue><fpage>837</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(98)07019-6</pub-id><pub-id pub-id-type="pmid">9742976</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Diabetes Control and Complications Trial Research Group</collab></person-group><article-title>The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus</article-title><source>N Engl J Med.</source><year>1993</year><volume>329</volume><issue>14</issue><fpage>977</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1056/NEJM199309303291401</pub-id><pub-id pub-id-type="pmid">8366922</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Standards of medical care in diabetes &#x02013; 2015: summary of revisions. Diabetes care. 2015; 38(Suppl):S4. doi:10.2337/dc15-S003.</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaede</surname><given-names>P</given-names></name><name><surname>Lund-Andersen</surname><given-names>H</given-names></name><name><surname>Parving</surname><given-names>HH</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name></person-group><article-title>Effect of a multifactorial intervention on mortality in type 2 diabetes</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><issue>6</issue><fpage>580</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0706245</pub-id><pub-id pub-id-type="pmid">18256393</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Neddermann</surname><given-names>D</given-names></name><name><surname>Piorunska-Stolzmann</surname><given-names>M</given-names></name><name><surname>Jagodzinski</surname><given-names>PP</given-names></name></person-group><article-title>Role of epigenetic mechanisms in the development of chronic complications of diabetes</article-title><source>Diabetes Res Clin Pract</source><year>2014</year><volume>105</volume><issue>2</issue><fpage>164</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2014.03.019</pub-id><pub-id pub-id-type="pmid">24814876</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadini</surname><given-names>GP</given-names></name></person-group><article-title>A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications</article-title><source>Diabetologia</source><year>2014</year><volume>57</volume><issue>1</issue><fpage>4</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/s00125-013-3087-6</pub-id><pub-id pub-id-type="pmid">24173366</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satya Krishna</surname><given-names>SV</given-names></name><name><surname>Kota</surname><given-names>SK</given-names></name><name><surname>Modi</surname><given-names>KD</given-names></name></person-group><article-title>Glycemic variability: clinical implications</article-title><source>Indian J Endocrinol Metab</source><year>2013</year><volume>17</volume><issue>4</issue><fpage>611</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.4103/2230-8210.113751</pub-id><pub-id pub-id-type="pmid">23961476</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnier</surname><given-names>L</given-names></name><name><surname>Wojtusciszyn</surname><given-names>A</given-names></name><name><surname>Colette</surname><given-names>C</given-names></name><name><surname>Owens</surname><given-names>D</given-names></name></person-group><article-title>The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes</article-title><source>Diabetes Technol Ther</source><year>2011</year><volume>13</volume><issue>8</issue><fpage>813</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1089/dia.2011.0049</pub-id><pub-id pub-id-type="pmid">21561372</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpert</surname><given-names>HA</given-names></name></person-group><article-title>The nuts and bolts of achieving end points with real-time continuous glucose monitoring</article-title><source>Diabetes Care</source><year>2008</year><volume>31</volume><issue>(Suppl 2)</issue><fpage>S146</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.2337/dc08-s238</pub-id><pub-id pub-id-type="pmid">18227476</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blevins</surname><given-names>T</given-names></name></person-group><article-title>Value and utility of self-monitoring of blood glucose in non-insulin-treated patients with type 2 diabetes mellitus</article-title><source>Postgrad Med</source><year>2013</year><volume>125</volume><issue>3</issue><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.3810/pgm.2013.05.2668</pub-id><pub-id pub-id-type="pmid">23748520</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dailey</surname><given-names>G</given-names></name></person-group><article-title>Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements</article-title><source>Mayo Clin Proc</source><year>2007</year><volume>82</volume><issue>2</issue><fpage>229</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/S0025-6196(11)61003-3</pub-id><pub-id pub-id-type="pmid">17290732</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnier</surname><given-names>L</given-names></name><name><surname>Colette</surname><given-names>C</given-names></name><name><surname>Owens</surname><given-names>DR</given-names></name></person-group><article-title>Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?</article-title><source>J Diabetes Sci Technol</source><year>2008</year><volume>2</volume><issue>6</issue><fpage>1094</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1177/193229680800200618</pub-id><pub-id pub-id-type="pmid">19885298</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>R</given-names></name><name><surname>Kuenen</surname><given-names>JC</given-names></name><name><surname>Carstensen</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Nathan</surname><given-names>DM</given-names></name><name><surname>Heine</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>HbA(1)(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study</article-title><source>Diabetologia</source><year>2011</year><volume>54</volume><issue>1</issue><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s00125-010-1918-2</pub-id><pub-id pub-id-type="pmid">20886203</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Service</surname><given-names>FJ</given-names></name><name><surname>Molnar</surname><given-names>GD</given-names></name><name><surname>Rosevear</surname><given-names>JW</given-names></name><name><surname>Ackerman</surname><given-names>E</given-names></name><name><surname>Gatewood</surname><given-names>LC</given-names></name><name><surname>Taylor</surname><given-names>WF</given-names></name></person-group><article-title>Mean amplitude of glycemic excursions, a measure of diabetic instability</article-title><source>Diabetes</source><year>1970</year><volume>19</volume><issue>9</issue><fpage>644</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.2337/diab.19.9.644</pub-id><pub-id pub-id-type="pmid">5469118</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molnar</surname><given-names>GD</given-names></name><name><surname>Taylor</surname><given-names>WF</given-names></name><name><surname>Ho</surname><given-names>MM</given-names></name></person-group><article-title>Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability</article-title><source>Diabetologia</source><year>1972</year><volume>8</volume><issue>5</issue><fpage>342</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/BF01218495</pub-id><pub-id pub-id-type="pmid">4641791</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueira</surname><given-names>FR</given-names></name><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Casali</surname><given-names>KR</given-names></name><name><surname>Tetelbom</surname><given-names>PS</given-names></name><name><surname>Henn</surname><given-names>NT</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>3</issue><fpage>e57733</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0057733</pub-id><pub-id pub-id-type="pmid">23536769</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Ribeiro</surname><given-names>PA</given-names></name><name><surname>Kramer</surname><given-names>CK</given-names></name><name><surname>Leitao</surname><given-names>CB</given-names></name><name><surname>Zucatti</surname><given-names>AT</given-names></name><name><surname>Azevedo</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis</article-title><source>JAMA</source><year>2011</year><volume>305</volume><issue>17</issue><fpage>1790</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1001/jama.2011.576</pub-id><pub-id pub-id-type="pmid">21540423</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Ribeiro</surname><given-names>PA</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis</article-title><source>Diabetologia</source><year>2013</year><volume>56</volume><issue>2</issue><fpage>242</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/s00125-012-2774-z</pub-id><pub-id pub-id-type="pmid">23160642</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figueira</surname><given-names>FR</given-names></name><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Cureau</surname><given-names>FV</given-names></name><name><surname>Zucatti</surname><given-names>AT</given-names></name><name><surname>Dalzochio</surname><given-names>MB</given-names></name><name><surname>Leitao</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Association between physical activity advice only or structured exercise training with blood pressure levels in patients with type 2 diabetes: a systematic review and meta-analysis</article-title><source>Sports Med</source><year>2014</year><volume>44</volume><issue>11</issue><fpage>1557</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s40279-014-0226-2</pub-id><pub-id pub-id-type="pmid">25047852</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibanez</surname><given-names>J</given-names></name><name><surname>Izquierdo</surname><given-names>M</given-names></name><name><surname>Arguelles</surname><given-names>I</given-names></name><name><surname>Forga</surname><given-names>L</given-names></name><name><surname>Larrion</surname><given-names>JL</given-names></name><name><surname>Garcia-Unciti</surname><given-names>M</given-names></name><etal/></person-group><article-title>Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes</article-title><source>Diabetes Care</source><year>2005</year><volume>28</volume><issue>3</issue><fpage>662</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.2337/diacare.28.3.662</pub-id><pub-id pub-id-type="pmid">15735205</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balducci</surname><given-names>S</given-names></name><name><surname>Zanuso</surname><given-names>S</given-names></name><name><surname>Nicolucci</surname><given-names>A</given-names></name><name><surname>Fernando</surname><given-names>F</given-names></name><name><surname>Cavallo</surname><given-names>S</given-names></name><name><surname>Cardelli</surname><given-names>P</given-names></name><etal/></person-group><article-title>Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss</article-title><source>Nutr Metab Cardiovasc Dis</source><year>2010</year><volume>20</volume><issue>8</issue><fpage>608</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2009.04.015</pub-id><pub-id pub-id-type="pmid">19695853</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagkalos</surname><given-names>M</given-names></name><name><surname>Koutlianos</surname><given-names>N</given-names></name><name><surname>Kouidi</surname><given-names>E</given-names></name><name><surname>Pagkalos</surname><given-names>E</given-names></name><name><surname>Mandroukas</surname><given-names>K</given-names></name><name><surname>Deligiannis</surname><given-names>A</given-names></name></person-group><article-title>Heart rate variability modifications following exercise training in type 2 diabetic patients with definite cardiac autonomic neuropathy</article-title><source>Br J Sports Med</source><year>2008</year><volume>42</volume><issue>1</issue><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2007.035303</pub-id><pub-id pub-id-type="pmid">17526623</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinik</surname><given-names>AI</given-names></name><name><surname>Erbas</surname><given-names>T</given-names></name></person-group><article-title>Diabetic autonomic neuropathy</article-title><source>Handb Clin Neurol.</source><year>2013</year><volume>117</volume><fpage>279</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-53491-0.00022-5</pub-id><pub-id pub-id-type="pmid">24095132</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geddes</surname><given-names>EL</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>K</given-names></name><name><surname>Reid</surname><given-names>WD</given-names></name><name><surname>Brooks</surname><given-names>D</given-names></name><name><surname>Crowe</surname><given-names>J</given-names></name></person-group><article-title>Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review</article-title><source>Respir Med</source><year>2008</year><volume>102</volume><issue>12</issue><fpage>1715</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2008.07.005</pub-id><pub-id pub-id-type="pmid">18708282</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>PR</given-names></name><name><surname>Guerra</surname><given-names>GM</given-names></name><name><surname>Borile</surname><given-names>S</given-names></name><name><surname>Rondon</surname><given-names>MU</given-names></name><name><surname>Alves</surname><given-names>MJ</given-names></name><name><surname>Negrao</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Inspiratory muscle training reduces sympathetic nervous activity and improves inspiratory muscle weakness and quality of life in patients with chronic heart failure: a clinical trial</article-title><source>J Cardiopulm Rehabil Prev</source><year>2012</year><volume>32</volume><issue>5</issue><fpage>255</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1097/HCR.0b013e31825828da</pub-id><pub-id pub-id-type="pmid">22785143</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaenisch</surname><given-names>RB</given-names></name><name><surname>Hentschke</surname><given-names>VS</given-names></name><name><surname>Quagliotto</surname><given-names>E</given-names></name><name><surname>Cavinato</surname><given-names>PR</given-names></name><name><surname>Schmeing</surname><given-names>LA</given-names></name><name><surname>Xavier</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Respiratory muscle training improves hemodynamics, autonomic function, baroreceptor sensitivity, and respiratory mechanics in rats with heart failure</article-title><source>J Appl Physiol (1985)</source><year>2011</year><volume>111</volume><issue>6</issue><fpage>1664</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01245.2010</pub-id><pub-id pub-id-type="pmid">21903877</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>AP</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name><name><surname>Balzan</surname><given-names>FM</given-names></name><name><surname>Mundstock</surname><given-names>L</given-names></name><name><surname>Ferlin</surname><given-names>EL</given-names></name><name><surname>Moraes</surname><given-names>RS</given-names></name></person-group><article-title>Inspiratory muscle training in type 2 diabetes with inspiratory muscle weakness</article-title><source>Med Sci Sports Exerc</source><year>2011</year><volume>43</volume><issue>7</issue><fpage>1135</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31820a7c12</pub-id><pub-id pub-id-type="pmid">21200342</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>AP</given-names></name><name><surname>Figueira</surname><given-names>FR</given-names></name><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Casali</surname><given-names>KR</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name></person-group><article-title>Inspiratory muscle loading: a new approach for lowering glucose levels and glucose variability in patients with Type 2 diabetes</article-title><source>Diabet Med</source><year>2015</year><volume>32</volume><issue>9</issue><fpage>1255</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/dme.12798</pub-id><pub-id pub-id-type="pmid">25970646</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Corr&#x000ea;a AP SB, Antunes CF, Figueira FR, Castro MA, Ribeiro JP., editor. Exacerbated inspiratory muscle metaboreflex in diabetic patients with autonomic neuropathy. In: 1<sup>st</sup> American Diabetes Association Middle East Congress: Diabetes Prevention and Treatment, Dubai, UAE 2012. Diabetes Care<italic>.</italic> 2012; 9(Suppl 4):S14.</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name></person-group><article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title><source>BMJ.</source><year>2010</year><volume>340</volume><fpage>c332</fpage><pub-id pub-id-type="doi">10.1136/bmj.c332</pub-id><pub-id pub-id-type="pmid">20332509</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Severo</surname><given-names>MD</given-names></name><name><surname>Leiria</surname><given-names>LF</given-names></name><name><surname>Ledur Pdos</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>AD</given-names></name><name><surname>Aguiar</surname><given-names>FM</given-names></name><name><surname>Massierer</surname><given-names>D</given-names></name><etal/></person-group><article-title>Association between erectile dysfunction and echocardiographic variables of ventricular hypertrophy and diastolic function in hypertensive patients with type 2 diabetes mellitus: a cross-sectional study</article-title><source>J Diabetes</source><year>2014</year><volume>6</volume><issue>6</issue><fpage>586</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1111/1753-0407.12133</pub-id><pub-id pub-id-type="pmid">24460859</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewing</surname><given-names>DJ</given-names></name><name><surname>Martyn</surname><given-names>CN</given-names></name><name><surname>Young</surname><given-names>RJ</given-names></name><name><surname>Clarke</surname><given-names>BF</given-names></name></person-group><article-title>The value of cardiovascular autonomic function tests: 10&#x000a0;years experience in diabetes</article-title><source>Diabetes Care</source><year>1985</year><volume>8</volume><issue>5</issue><fpage>491</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2337/diacare.8.5.491</pub-id><pub-id pub-id-type="pmid">4053936</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>H</given-names></name></person-group><article-title>Standardization of a computerized method for calculating autonomic function test responses in healthy subjects and patients with diabetes mellitus</article-title><source>Braz J Med Biol Res</source><year>1997</year><volume>30</volume><issue>2</issue><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X1997000200007</pub-id><pub-id pub-id-type="pmid">9239305</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dall&#x02019;Ago</surname><given-names>P</given-names></name><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>Guths</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial</article-title><source>J Am Coll Cardiol</source><year>2006</year><volume>47</volume><issue>4</issue><fpage>757</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2005.09.052</pub-id><pub-id pub-id-type="pmid">16487841</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callegaro</surname><given-names>CC</given-names></name><name><surname>Martinez</surname><given-names>D</given-names></name><name><surname>Ribeiro</surname><given-names>PA</given-names></name><name><surname>Brod</surname><given-names>M</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Augmented peripheral chemoreflex in patients with heart failure and inspiratory muscle weakness</article-title><source>Respir Physiol Neurobiol</source><year>2010</year><volume>171</volume><issue>1</issue><fpage>31</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2010.01.009</pub-id><pub-id pub-id-type="pmid">20096381</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society/European Respiratory Society</collab></person-group><article-title>ATS/ERS statement on respiratory muscle testing</article-title><source>Am J Respir Crit Care Med.</source><year>2002</year><volume>166</volume><issue>4</issue><fpage>518</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1164/rccm.166.4.518</pub-id><pub-id pub-id-type="pmid">12186831</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovatchev</surname><given-names>BP</given-names></name><name><surname>Otto</surname><given-names>E</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name><name><surname>Gonder-Frederick</surname><given-names>L</given-names></name><name><surname>Clarke</surname><given-names>W</given-names></name></person-group><article-title>Evaluation of a new measure of blood glucose variability in diabetes</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><issue>11</issue><fpage>2433</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.2337/dc06-1085</pub-id><pub-id pub-id-type="pmid">17065680</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>NR</given-names></name><name><surname>Oliver</surname><given-names>NS</given-names></name><name><surname>Choudhary</surname><given-names>P</given-names></name><name><surname>Levy</surname><given-names>JC</given-names></name><name><surname>Hindmarsh</surname><given-names>P</given-names></name><name><surname>Matthews</surname><given-names>DR</given-names></name></person-group><article-title>Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups</article-title><source>Diabetes Technol Ther</source><year>2011</year><volume>13</volume><issue>9</issue><fpage>921</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1089/dia.2010.0247</pub-id><pub-id pub-id-type="pmid">21714681</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malliani</surname><given-names>A</given-names></name><name><surname>Pagani</surname><given-names>M</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Cerutti</surname><given-names>S</given-names></name></person-group><article-title>Cardiovascular neural regulation explored in the frequency domain</article-title><source>Circulation</source><year>1991</year><volume>84</volume><issue>2</issue><fpage>482</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.84.2.482</pub-id><pub-id pub-id-type="pmid">1860193</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porta</surname><given-names>A</given-names></name><name><surname>Guzzetti</surname><given-names>S</given-names></name><name><surname>Montano</surname><given-names>N</given-names></name><name><surname>Furlan</surname><given-names>R</given-names></name><name><surname>Pagani</surname><given-names>M</given-names></name><name><surname>Malliani</surname><given-names>A</given-names></name><etal/></person-group><article-title>Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series</article-title><source>IEEE Trans Biomed Eng</source><year>2001</year><volume>48</volume><issue>11</issue><fpage>1282</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1109/10.959324</pub-id><pub-id pub-id-type="pmid">11686627</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherwood</surname><given-names>A</given-names></name><name><surname>Allen</surname><given-names>MT</given-names></name><name><surname>Fahrenberg</surname><given-names>J</given-names></name><name><surname>Kelsey</surname><given-names>RM</given-names></name><name><surname>Lovallo</surname><given-names>WR</given-names></name><name><surname>van Doornen</surname><given-names>LJ</given-names></name></person-group><article-title>Methodological guidelines for impedance cardiography</article-title><source>Psychophysiology</source><year>1990</year><volume>27</volume><issue>1</issue><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1111/j.1469-8986.1990.tb02171.x</pub-id><pub-id pub-id-type="pmid">2187214</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempsey</surname><given-names>JA</given-names></name><name><surname>Amann</surname><given-names>M</given-names></name><name><surname>Romer</surname><given-names>LM</given-names></name><name><surname>Miller</surname><given-names>JD</given-names></name></person-group><article-title>Respiratory system determinants of peripheral fatigue and endurance performance</article-title><source>Med Sci Sports Exerc</source><year>2008</year><volume>40</volume><issue>3</issue><fpage>457</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e31815f8957</pub-id><pub-id pub-id-type="pmid">18379207</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>AL</given-names></name><name><surname>Killian</surname><given-names>KJ</given-names></name><name><surname>Summers</surname><given-names>E</given-names></name><name><surname>Jones</surname><given-names>NL</given-names></name></person-group><article-title>Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume>152</volume><issue>6 Pt 1</issue><fpage>2021</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.152.6.8520771</pub-id><pub-id pub-id-type="pmid">8520771</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roseguini</surname><given-names>BT</given-names></name><name><surname>Alves</surname><given-names>CN</given-names></name><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>Stein</surname><given-names>R</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name></person-group><article-title>Muscle metaboreflex contribution to resting limb haemodynamic control is preserved in older subjects</article-title><source>Clin Physiol Funct Imaging</source><year>2007</year><volume>27</volume><issue>5</issue><fpage>335</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1475-097X.2007.00756.x</pub-id><pub-id pub-id-type="pmid">17697031</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><name><surname>Solomon</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><etal/></person-group><article-title>Physical activity and risk for cardiovascular events in diabetic women</article-title><source>Ann Intern Med</source><year>2001</year><volume>134</volume><issue>2</issue><fpage>96</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-134-2-200101160-00009</pub-id><pub-id pub-id-type="pmid">11177312</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winnick</surname><given-names>JJ</given-names></name><name><surname>Sherman</surname><given-names>WM</given-names></name><name><surname>Habash</surname><given-names>DL</given-names></name><name><surname>Stout</surname><given-names>MB</given-names></name><name><surname>Failla</surname><given-names>ML</given-names></name><name><surname>Belury</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity</article-title><source>J Clin Endocrinol Metab</source><year>2008</year><volume>93</volume><issue>3</issue><fpage>771</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-1524</pub-id><pub-id pub-id-type="pmid">18073312</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howorka</surname><given-names>K</given-names></name><name><surname>Pumprla</surname><given-names>J</given-names></name><name><surname>Haber</surname><given-names>P</given-names></name><name><surname>Koller-Strametz</surname><given-names>J</given-names></name><name><surname>Mondrzyk</surname><given-names>J</given-names></name><name><surname>Schabmann</surname><given-names>A</given-names></name></person-group><article-title>Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy</article-title><source>Cardiovasc Res</source><year>1997</year><volume>34</volume><issue>1</issue><fpage>206</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(97)00040-0</pub-id><pub-id pub-id-type="pmid">9217892</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminski</surname><given-names>DM</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name><name><surname>da Silva</surname><given-names>AM</given-names></name><name><surname>Soares</surname><given-names>PP</given-names></name><name><surname>Plentz</surname><given-names>RD</given-names></name><name><surname>Dall&#x02019;Ago</surname><given-names>P</given-names></name></person-group><article-title>Inspiratory muscle weakness is associated with autonomic cardiovascular dysfunction in patients with type 2 diabetes mellitus</article-title><source>Clin Auton Res</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>29</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s10286-010-0087-1</pub-id><pub-id pub-id-type="pmid">21052769</pub-id></element-citation></ref></ref-list></back></article>